RubenJonasColmanMDPhD

Pediatric Inflammatory Bowel Disease Gastroenterology

Pediatric Gastroenterologist

Dr. Colman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board certified pediatric gastroenterologist specializing in the care for children with pediatric inflammatory bowel disease such as Crohn's disease and ulcerative colitis. As a physician-scientist, I study innovative ways to directly improve management and treatment for children with these diseases.

University of Amsterdam Faculty of MedicinePhD, 2014 - 2023
Cincinnati Children's Hospital medical CenterAdvanced Pediatric Inflammatory Bowel Disease, 2021 - 2022
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Gastroenterology, 2018 - 2021
St Barnabas HospitalResidency, Pediatrics, 2015 - 2018
University of Amsterdam Faculty of MedicineClass of 2012

PubMed

28 citations
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Britt Christensen, Ruben J. Colman, Dejan Micic, Peter R. Gibson, Sarah R. Goeppinger
Inflammatory Bowel Diseases. 2018-03-19
53 citations
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
Britt Christensen, Peter R. Gibson, Dejan Micic, Ruben J. Colman, Sarah R. Goeppinger
Clinical Gastroenterology and Hepatology. 2019-02-01
16 citations
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
Ruben J. Colman, Yi-Ting Tsai, Kimberly Jackson, Brendan M. Boyle, Joshua D. Noe
Inflammatory Bowel Diseases. 2021-06-15

Journal Articles

Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine
Ruben Colman, MD, Frontiers in Pediatric Gastroenterology, Hepatology and Nutrition

Abstracts/Posters

Fecal alpha-1-Antitrypsin as a Biomarker for Disease Activity in Ulcerative Colitis
Colman RJ, Rubin DT, American College of Gastroenterology Annual Meeting, Philadelphia, PA, 10/20/2014
Efficacy of High-Dose versus Low-Dose Methotrexate in Combination Therapy for Inflammatory Bowel Disease
Colman RJ, Rubin DT, American College of Gastroenterology Annual Meeting, American College of Gastroenterology Annual Meeting, 10/20/2014
Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores.
Lee JJ, Colman RJ, Mitchell PD, Atmadja ML, Bousvaros A, Lightdale JR, North American Pediatric Gastroenterology, Hepatology and Nutrition annual meeting, New Orleans, LA, 10/23/2010

Committee Member, IBD Committee - NASPGHAN 2022 - Present
Committee Member, Pediatric Affairs Committee - Crohn's Colitis Foundation 2022 - Present
SIG Member, Data Science Special Interest Group - NASPGHAN 2021 - Present
Committee Member, Research Committee - NASPGHAN 2019 - 2022